Franklin Resources Inc Iveric Bio, Inc. Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$26.24 - $39.63 $43.7 Million - $66 Million	-1,664,759 Reduced 96.69%	57,039 $2.24 Million
Q1 2023 May 12, 2023	BUY	$18.67 - $24.56 $203,409 - $267,581	10,895 Added 0.64%	1,721,798 $41.9 Million
Q4 2022 Feb 10, 2023	SELL	$17.24 - $23.95 $9,154 - $12,717	-531 Reduced 0.03%	1,710,903 $36.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $4.54 Million - $8.98 Million	482,934 Added 39.31%	1,711,434 $30.7 Million
Q2 2022 Aug 11, 2022	BUY	$9.12 - $18.9 $6,675 - $13,834	732 Added 0.06%	1,228,500 $11.8 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $22,173 - $30,714	-1,825 Reduced 0.15%	1,227,768 $20.7 Million
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $15.5 Million - $21.1 Million	1,122,461 Added 1047.74%	1,229,593 $20.6 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $757,423 - $1.87 Million	107,132 New	107,132 $1.74 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.